ResMed Inc. Cash and Cash Equivalents, Fair Value Disclosure
ResMed Inc. (RMD) had Cash and Cash Equivalents, Fair Value Disclosure of $776.07 million as of 2012-03-31, per its 10-Q filed 2012-05-01.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2012-05-01
- 2012-03-31: Cash and Cash Equivalents, Fair Value Disclosure $776.07M.
- 2011-12-31: Cash and Cash Equivalents, Fair Value Disclosure $723.23M.
- 2011-09-30: Cash and Cash Equivalents, Fair Value Disclosure $610.06M.
- 2011-06-30: Cash and Cash Equivalents, Fair Value Disclosure $735.27M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2012-03-31 | $776.07M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $723.23M 10-Q · filed 2012-02-02 |
| 2011-09-30 | $610.06M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $735.27M 10-K · filed 2011-08-17 |